Garry Tan is CEO of Y Combinator, and he recently described a peripheral brain that he created from OpenClaw and Hermes Agents. He obviously put a lot of work into it, but what struck me was the amount of stress he must be going through. He doesn't go into detail regarding his "hard period" but it made be wonder what people are going through these days. How many need therapists to get through the day? His Gbrain tool that he crafted seems to be even better than a therapist. He uses frontier models as his LLM, and I wonder what precautions he has taken about how his content is being handled on the other side. But the drive to create a "thing" that understands you well is elemental. We all strive to find that something or someone.
––– 凄い –––
Claude Mythos found a CVE (common vulnerability and exposures) in FreeBSDS dating back to around 2000. It was not detected and was copied over and over, until being detected now. This is scary.
FreeBSD’s CVE was caused by human negligence in the early 2000’s.
But, in 2026, decades-old flaws are being baked directly into our systems faster than ever. LLMs, as they configure our environments and write new code, regurgitate the same insecure patterns they were trained on.
Advanced models don't need to be highly creative to shut down a company or a power grid. They just need to act as powerful pattern-matchers, spotting and exploiting the legacy bugs that weaker AI models carelessly copy-pasted into the environment.
“Before the meeting even starts,” he told DealBook, “when I see that A.I. note taker pop up, I’ll just say: ‘Hey, Mike, Jim, Barbara, I see the A.I. note taker popped up. I’m going to turn it off and kick it out of the meeting.’”
This happens more and more. “Everybody and their mother is using these things,” Gifford said. “Executives are using them, boards are using them, nonexecutive businesspeople are using them.”
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer. The clinical trial that excited pancreatic cancer oncologists was puiblished in the New England Journal of Medicine. When given as second-line therapy, almost everyone saw stable disease or tumor shrinkage as seen in this waterfall plot.
And look at that overall survival – wow! Ordinarily, the median survival with second-line chemo is 6 to 8 months. In this study it was 15.6 months. Incredible.
––– 凄い –––
AI Luddites are tired of having to explain why they refuse to use generative AI. Well, you do you.
––– 良くない–––
Scientists Prolong the Life of Mice With Invisible Energy Fields, New Study Shows. This seemed kinda fringe at first, but it got published in Cell, so it may be something. I can't access the article, so I don't know the details of the electromagnetic field switch.
Or maybe the secret of youth is in poop. Yes, poop from young mice reverses signs of age-related decline in older mice. No need for plasma donations, maybe.
––– 凄い –––
Robot Dogs Are A Security Nightmare. Oh boy, people need to watch this video. We use stuff from China all the time, but when it comes to AI tech, we really need to watch out. These AI robot dogs may be the foothold that some nefarious force uses to eventually cause some real havoc. An innocent firmware update in the future, and all hell could break loose. We really need to have tech expertise in the federal government.
––– 良くない–––